Company / Tangible Book Value per Share
Xenon Pharmaceuticals Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.34
FY2025
5-year range
$7.34 / $13.87
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#71 of 209
Health Care
What the data says
At $7.34, Xenon Pharmaceuticals Inc.'s tangible book value per share ranks #71 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $3.55 in FY2019 to $13.87 in FY2023.
Based on SEC 10-K filings.
7.34 in FY2025 with a 5-year CAGR of +8.2%.
Declined from $13.87 to $7.34 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
-92.1% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 24.3% year-over-year.
- Ranks #71 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2023.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.34 | -24.3% |
| FY2024 | $9.69 | -30.1% |
| FY2023 | $13.87 | +16.4% |
| FY2022 | $11.92 | -5.5% |
| FY2021 | $12.61 | +154.1% |
| FY2020 | $4.96 | +39.9% |
| FY2019 | $3.55 | -38.2% |
| FY2018 | $5.74 | +61.0% |
| FY2017 | $3.56 | -19.8% |
| FY2016 | $4.44 | +3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026